PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 163 (xsd:integer)
nif:isString
  • In addition to targeting RTKs, sorafenib also affects the PI3-K/Akt pathways and their negative regulator, the lipid phosphatase and tensin homolog (PTEN) pathway.
rdf:type